The association between serum adiponectin levels and nutritional status of hemodialysis patients

Renal Failure

Volumn 33, Issue 5, 2011, Pages 506-511

  Lee, Yu Ji ^a   Cho, Seong ^a   Kim, Sung Rok ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

Adiponectin; hemodialysis; malnutrition; malnutrition inflammation score; subjective global assessment

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; GLUCOSE; SERUM ALBUMIN; TRANSFERRIN; TRIACYLGLYCEROL; UREA;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD LEVEL; BODY COMPOSITION; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; LEAN BODY WEIGHT; MALE; MALNUTRITION; MALNUTRITION INFLAMMATION SCORE; NUTRITIONAL STATUS; PRIORITY JOURNAL; SCORING SYSTEM; SUBJECTIVE GLOBAL ASSESSMENT; TRANSFERRIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL;

ADIPONECTIN; ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NUTRITIONAL STATUS; RENAL DIALYSIS;

EID: 79956269169     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2011.576794     Document Type: Article

References (28)

1. Ouchi N, Kihara S, Arita Y, et al. Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin. Circulation. 1999;100:2473-2476. (Pubitemid 30005109)
2. Okamoto Y, Kihara S, Ouchi N, et al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation. 2002;106:2767-2770. (Pubitemid 35396973)
3. Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K. Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol. 2003;14:561-566. (Pubitemid 41623184)
4. Ouchi N, Shibata R, Walsh K. Cardioprotection by adiponectin. Trends Cardiovasc Med. 2006;16:141-146. (Pubitemid 43867326)
5. Cnop M, Havel PJ, Utzschneider KM, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: Evidence for independent roles of age and sex. Diabetologia. 2003;46:459-469. (Pubitemid 36577787)
6. Tschritter O, Fritsche A, Thamer C, et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes. 2003;52:239-243. (Pubitemid 36173174)
7. Nanayakkara PW, Le Poole CY, Fouque D, et al. Plasma adiponectin concentration has an inverse and a non linear association with estimated glomerular filtration rate in patients with K/DOQI 3-5 chronic kidney disease. Clin Nephrol. 2009;72:21-30.
8. Park SH, Carrero JJ, Lindholm B, Stenvinkel P. Adiponectin in chronic kidney disease has an opposite impact on protein-energy wasting and cardiovascular risk: Two sides of the same coin. Clin Nephrol. 2009;72:87-96.
9. Zoccali C, Tripepi G, Cambareri F, et al. Adipose tissue cytokines, insulin sensitivity, inflammation, and cardiovascular outcomes in end-stage renal disease patients. J Ren Nutr. 2005;15:125-130. (Pubitemid 40093696)
10. Komura N, Kihara S, Sonoda M, et al. Increment and impairment of adiponectin in renal failure. Cardiovasc Res. 86:471-477.
11. Ge YQ, Wu ZL, Xu YZ, Liao LT. Study on nutritional status of maintenance hemodialysis patients. Clin Nephrol. 1998;50: 309-314. (Pubitemid 28508526)
12. Herselman M, Moosa MR, Kotze TJ, Kritzinger M, Wuister S, Mostert D. Protein-energy malnutrition as a risk factor for increased morbidity in long-term hemodialysis patients. J Ren Nutr. 2000;10:7-15.
13. Lowrie EG, Huang WH, Lew NL. Death risk predictors among peritoneal dialysis and hemodialysis patients: A preliminary comparison. Am J Kidney Dis. 1995;26:220-228.
14. Laville M, Fouque D. Nutritional aspects in hemodialysis. Kidney Int Suppl. 2000;76:S133-S139. (Pubitemid 30612813)
15. K/DOQI, National Kidney Foundation. Clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis. 2000;35:S1-S140.
16. Blumenkrantz MJ, Kopple JD, Gutman RA, et al. Methods for assessing nutritional status of patients with renal failure. Am J Clin Nutr. 1980;33:1567-1585. (Pubitemid 10013705)
17. Formica C, Atkinson MG, Nyulasi I, McKay J, Heale W, Seeman E. Body composition following hemodialysis: Studies using dual-energy X-ray absorptiometry and bioelectrical impedance analysis. Osteoporos Int. 1993;3:192-197. (Pubitemid 23194453)
18. Malgorzewicz S, Lichodziejewska-Niemierko M, Aleksandrowicz-Wrona E, Swietlik D, Rutkowski B, Lysiak-Szydlowska W. Adipokines, endothelial dysfunction and nutritional status in peritoneal dialysis patients. Scand J Urol Nephrol. 2010;44:445-451.
19. Dervisoglu E, Eraldemir C, Kalender B, Kir HM, Caglayan C. Adipocytokines leptin and adiponectin, and measures of malnutrition-inflammation in chronic renal failure: Is there a relationship? J Ren Nutr. 2008;18:332-337. (Pubitemid 351814999)
20. Oh DK, Ciaraldi T, Henry RR. Adiponectin in health and disease. Diabetes Obes Metab. 2007;9:282-289. (Pubitemid 46502045)
21. Odamaki M, Furuya R, Kinumura Y, Ikegaya N, Kumagai H. Association between plasma adiponectin concentration and visceral fat accumulation in hemodialysis patients. Nephron Clin Pract. 2006;102:c8-c13. (Pubitemid 43250927)
22. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2001;38:1251-1263. (Pubitemid 34193111)
23. Huang JW, Yen CJ, Chiang HW, Hung KY, Tsai TJ, Wu KD. Adiponectin in peritoneal dialysis patients: A comparison with hemodialysis patients and subjects with normal renal function. Am J Kidney Dis. 2004;43:1047-1055.
24. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med. 2001;7:947-953. (Pubitemid 32756433)
25. Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest. 2001;108: 1875-1881. (Pubitemid 34015133)
26. Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001;7: 941-946. (Pubitemid 32756432)
27. Qiao L, Zou C, van der Westhuyzen DR, Shao J. Adiponectin reduces plasma triglyceride by increasing VLDL triglyceride catabolism. Diabetes. 2008;57:1824-1833.
28. Devaraj S, Torok N, Dasu MR, Samols D, Jialal I. Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells: Evidence for an adipose tissue-vascular loop. Arterioscler Thromb Vasc Biol. 2008;28:1368-1374.